- BioNJ launches initiative to facilitate equity in clinical trials
- BioNJ Announces the Launch of Its Health Equity in Clinical Trials Initiative
- A Missed Opportunity for Patients and for Medical Innovation
- BioNJ President and CEO Debbie Hart Appointed as New Commission on Science, Innovation and Technology Chair
- BioNJ Releases Speakers and Agenda for 2022 C-Suite Summit
- BioNJ holds in-person Manufacturing Brief at NJIT
- OPINION: Let’s be honest about the $740B US Inflation Reduction Act
- WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey
- NJBIZ Conversations: Debbie Hart
- CSIT Awards Nearly $4 Million to 45 NJ Startups Through Catalyst And Clean Tech Seed Grant Programs
- N.J. already planning push to bring Eli Lilly to state
- BioNJ Adds Two Executive Directors and Promotes Three
- NY/NJ Market No. 4 in Nation’s Life Sciences Talent
- Tech Trends: Entrepreneur and investor Harvey Homan gives advice at Princeton event
- NJ Health Commissioner on Pandemic Leadership, Partnerships & Innovation
- NJ’s Burgeoning Biotech Industry – Scientific advances and an advantageous New Jersey environment have fueled industry growth.
- ROI-NJ PM: ROI-NJ presents the ROI Influencers: Manufacturing 2022 – Debbie Hart
- Spotlight On: Debbie Hart, President & CEO, BioNJ
- NJ Spotlight Roundtable – COVID
- BioNJ’s Annual Dinner Meeting & Innovation Celebration to Honor New Jersey’s Innovators, COVID-19 Heroes and the Patients Who Inspire Them
- Why N.J. CAN be ‘Medicine Chest’ — and home to innovative companies of the future. An Op-Ed by #BioNJ President and CEO Debbie Hart.
- BioNJ Announces Lineup for 2022 BioPartnering Conference
- The 2022 NJBIZ Power 100
- BioNJ Elects Board Officers and Trustees
- Verve Group Consulting Announces Sponsorship of BioNJ’s 2022 IT/Cybersecurity Awareness Newsletter Series
- Council of State Bioscience Associations Elects New Board Leadership
- ROI-NJ Presents the ROI Influencers: Health Care 2021
- BioNJ Releases White Paper: “Prescription Drug Affordability Boards: Myths vs. Facts on Drug Supply Chain”
- 2 N.J. Organizations Sign MOUs With Leading Indian Biotech Organization
- PharmaVOICE Announces Its Red Jacket Award Honorees
- Waiving IP Rights for COVID-19 Vaccines is Dangerous for Innovation, Jobs and Patients | Opinion
- BioNJ White Paper: Myths & Facts of Prescription Drug Affordability Boards
- New Jersey Democrats want ‘fairness’ in Biden’s trillion-dollar agenda. They’re in for a fight.
- 2021 edition of the United States Pharmaceutical and Biopharmaceutical Industry Report
- BioPartnering Conference Reveals Pandemic’s Silver Lining
- The state’s life sciences industry plays a significant role in the fight against everything from cancer to COVID-19.
- Global Business Reports Interview with BioNJ Founding President & CEO Debbie
- Life Sciences in New Jersey
The state’s life sciences industry plays a significant role in the fight against everything from cancer to COVID-19. - What drove the surprising rebound for these 2 mega-industries in N.J.
- NJBIZ 2021 Health Care Power 50
- BioNJ is Taking an In-Depth Look at Diversity, Equity and Inclusion
- NJBIZ Conversations: Will Lewis
- Global Business Reports: Interview With Debbie Hart
- Tech Trends: Panel sees chance for N.J. to capitalize on COVID-induced workplace trends
- Praising the Cancer-Fighting Work of Innovative Industries
- Vaccines, hospitals and the business side of the pandemic | NJ Business Beat
- Manufacturing, supply, distribution: the next high hurdles on the COVID-19 horizon
- Panel Sees Opportunity for New Jersey to Capitalize on COVID-induced
Workplace Trends - Op-Ed: Protect homegrown New Jersey medical innovations that could help end COVID-19
- Everyone is hoping for silver bullet for COVID-19, but N.J.’s biopharma experts know collaboration could wind up key
- NJ Colleges Expect Fewer International Students, Businesses also Reckon with Fewer Skilled Foreign Workers
- NJBIZ Conversations: Debbie Hart
- NJ Life Sciences Companies Tackle COVID-19
- Coughlin announces all-star lineup for his Economic Advisory Counci
- Here are members of Murphy’s Restart and Recovery Advisory Council
- BIO Summit Accelerates Collaboration in Fight Against COVID-19
- 2020 NJBIZ Health Care Power 50
State Leaders in Life Sciences Weigh in on Drug Importation
The ROI Influencers Power List 2020: Associations - N.J.’s Innovation Evergreen Fund: Attracting investments today for tomorrow’s cures
- Pharma exec: Reliance on males in clinical trials has limited advances in women’s health
- Health care experts: True gender equity means equity at all positions in company, including senior leadership
- Lower Drug Costs Now Act passes US House
- Bitter pills | Pharmaceutical companies face economic and political challenges in 2020
- Op-Ed: Unsafe crossing — Drug importation is dangerous for patients and will not improve health care affordability
- Op-Ed: A Troubling Method of Curbing Health Care Costs Is Gaining Ground
- Show & Tell: Are patients and the innovation economy under threat from proposed regulation?
- The 2019 ROI Influencers: Health Care list
- Experts say New Jersey’s life science industry continues to thrive
- Still the Medicine Chest of the World
- Business leaders voice support for Murphy’s incentive proposals
- Innovating for an Innovation Ecosystem
- Making discoveries … and companies: How CDI can give big boost to N.J. economy
- Innovation laboratory: Why the Garden State continues to attract life science companies
- Patients Are Waiting…
- Meet the chairs for NJ’s $20M higher education investment plan
- GBR Interview with Debbie Hart, President & CEO, BioNJ
- BioNJ celebrates innovation at its annual meeting
- Is NJ Still ‘Hot’ for Life Sciences Innovation?
- Mind matters: Tracy Fink’s emotional intelligence journey has led her from corporate world to mindfulness coaching
- Here’s to Your Health: Support Biomedical Innovation in 2019
- Murphy unveils picks for innovation commission
- NJ Life Sciences Industry a National Leader in Fight Against Cancer
- Mallinckrodt exec talks about inspiration, specialization at BioNJ’s Women in STEM event
- Garden State Lawmakers Want To Bringing Clinical Trials Home
- Thomas O. Daniel Research Incubator And Collaboration Center Selects PhageNova Bio, Inc. As First Client
- September 13, 2018: NJTV News with Mary Alice Williams
- Murphy re-establishes Commission on Science, Technology and Innovation
- Taxing question: BioNJ’s Hart is optimistic about life science sector, but with caution
- Murphy announces new EDA incentives
- New BioNJ program sees new grad land 2-year entrepreneurship fellowship at 4 life sciences firms
- BioNJ Launches Inaugural Entrepreneurship Fellowship Program
- Zwicker on Biotech Report: Public dollars, leveraged with private dollars, are key to innovation
- BioNJ’s Hart: It’s All About ‘the Company We Keep’
- With Mentors, Models, and #MeToo, Femtech Comes of Age
- Study: NJ among tops in biopharma
- Medicine for the future: Innovation and patient access
- Staying aloft: Incubators rise to keep state atop of biotech R&D
- Genewiz Celebrates Newly Expanded International Headquarters in South Plainfield on DNA Day
- Database will reveal New Jersey’s research assets to fuel innovation
- Health care leaders pin hopes on Gottlieb to alleviate drug pricing issue
- NJ Biotechnology Task Force Hears Testimony from Renowned Innovation Expert
- Biopharma Industry Report Offers Ideas to Boost Lagging Sector
- BioNJ hopes to reverse N.J.’s decline in biopharma
- Cheerleaders and dollars: Prescription for growing NJ’s biopharma industry
- BioNJ: State must do more to strengthen biopharma sector Trade group’s study presses need for more VC funding, academic partnerships to stem decline
- Biotech and Life Sciences: Alive and Well in New Jersey
- NJ to Shine at BIO International
- BioNJ Helps Biotechs Grow in the Garden State
- BioNJ and HINJ Commentary: To Save Patients, Keep New Jersey’s Life Sciences Industry Healthy
- NJ’s Biotech Industry Backs Bill Setting Rules For New Drug Prescriptions
- Debbie Hart participates in a discussion on Transforming U.S. Workforce Development Policies for the 21st Century
- Innovation. Opportunity. Hope. CELEBRATING LIFE SCIENCES IN NEW JERSEY